Skip to content

US · VERO · MEDICAL - DEVICES

Venus Concept Inc. (VERO) intrinsic value and stock valuation

$0.31as of 2026-04-06 · Mkt cap 3.92M

Data updated · price as of 2026-04-06

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Venus Concept Inc. DCF and intrinsic value

InvestorsCraft values VERO with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from VERO’s statements →

Healthcare · Medical - Devices Toronto, ON M2J 4Y8 venusconcept.com

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

About Venus Concept Inc.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.

CEO
Rajiv Kanishka Liyanaarchchie De Silva
Employees
292
Beta
-0.11

Explore

Frequently asked questions

What is the intrinsic value of Venus Concept Inc. (VERO)?

InvestorsCraft does not currently publish an intrinsic value for VERO. How the IC value is calculated.

Is VERO undervalued?

InvestorsCraft does not publish an undervaluation signal for VERO at this time.

How is the intrinsic value calculated?

InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

How often is this page updated?

Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Aug 11, 2026.

Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.